Structure

Physi-Chem Properties

Molecular Weight:  678.3
Volume:  696.633
LogP:  4.608
LogD:  2.841
LogS:  -4.184
# Rotatable Bonds:  10
TPSA:  165.89
# H-Bond Aceptor:  11
# H-Bond Donor:  3
# Rings:  4
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.226
Synthetic Accessibility Score:  5.529
Fsp3:  0.474
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.34
MDCK Permeability:  7.486618414986879e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.044
Human Intestinal Absorption (HIA):  0.204
20% Bioavailability (F20%):  0.844
30% Bioavailability (F30%):  0.979

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.292
Plasma Protein Binding (PPB):  97.57975006103516%
Volume Distribution (VD):  1.898
Pgp-substrate:  6.331311225891113%

ADMET: Metabolism

CYP1A2-inhibitor:  0.035
CYP1A2-substrate:  0.027
CYP2C19-inhibitor:  0.023
CYP2C19-substrate:  0.065
CYP2C9-inhibitor:  0.568
CYP2C9-substrate:  0.359
CYP2D6-inhibitor:  0.245
CYP2D6-substrate:  0.055
CYP3A4-inhibitor:  0.844
CYP3A4-substrate:  0.353

ADMET: Excretion

Clearance (CL):  4.219
Half-life (T1/2):  0.326

ADMET: Toxicity

hERG Blockers:  0.821
Human Hepatotoxicity (H-HT):  0.987
Drug-inuced Liver Injury (DILI):  0.957
AMES Toxicity:  0.004
Rat Oral Acute Toxicity:  0.45
Maximum Recommended Daily Dose:  0.964
Skin Sensitization:  0.127
Carcinogencity:  0.028
Eye Corrosion:  0.003
Eye Irritation:  0.009
Respiratory Toxicity:  0.968

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473301

Natural Product ID:  NPC473301
Common Name*:   1Alpha,13Beta,14Alpha-Trihydroxy-3Beta,7Beta-Dibenzoyloxy-9Beta,15Beta-Diacetoxyjatropha-5,11 E-Diene
IUPAC Name:   [(1S,2S,3S,3aS,4R,5S,6E,9S,11R,12Z,13aS)-3a,9-diacetyloxy-1-benzoyloxy-3,4,5-trihydroxy-2,5,8,8,12-pentamethyl-1,2,3,4,9,10,11,13a-octahydrocyclopenta[12]annulen-11-yl] benzoate
Synonyms:  
Standard InCHIKey:  IRMXGIKDWJKAIM-SXCTYVFVSA-N
Standard InCHI:  InChI=1S/C38H46O11/c1-22-20-28-31(48-34(43)27-16-12-9-13-17-27)23(2)32(41)38(28,49-25(4)40)35(44)37(7,45)19-18-36(5,6)30(46-24(3)39)21-29(22)47-33(42)26-14-10-8-11-15-26/h8-20,23,28-32,35,41,44-45H,21H2,1-7H3/b19-18+,22-20-/t23-,28+,29-,30+,31+,32+,35-,37+,38+/m1/s1
SMILES:  CC1C(C2C=C(C(CC(C(C=CC(C(C2(C1O)OC(=O)C)O)(C)O)(C)C)OC(=O)C)OC(=O)C3=CC=CC=C3)C)OC(=O)C4=CC=CC=C4
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL398938
PubChem CID:   23642402
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0002877] Jatrophane and cyclojatrophane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31109 Pedilanthus tithymaloides Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[17844996]
NPO31109 Pedilanthus tithymaloides Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO31109 Pedilanthus tithymaloides Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 5900.0 nM PMID[475951]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis MIC = 12.5 ug.mL-1 PMID[475951]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473301 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9692 High Similarity NPC311492
0.9692 High Similarity NPC28836
0.9621 High Similarity NPC27721
0.9615 High Similarity NPC472248
0.9552 High Similarity NPC242355
0.9545 High Similarity NPC202729
0.9538 High Similarity NPC233692
0.9538 High Similarity NPC239358
0.9538 High Similarity NPC233860
0.947 High Similarity NPC200154
0.9281 High Similarity NPC205389
0.9248 High Similarity NPC153617
0.9149 High Similarity NPC232583
0.9149 High Similarity NPC25484
0.9118 High Similarity NPC121268
0.9118 High Similarity NPC53361
0.9091 High Similarity NPC477100
0.9091 High Similarity NPC475508
0.9091 High Similarity NPC477098
0.9051 High Similarity NPC475660
0.9044 High Similarity NPC327511
0.9044 High Similarity NPC205305
0.9037 High Similarity NPC149401
0.9037 High Similarity NPC279637
0.8993 High Similarity NPC45307
0.8986 High Similarity NPC474303
0.8986 High Similarity NPC475413
0.8963 High Similarity NPC298547
0.8963 High Similarity NPC324898
0.8963 High Similarity NPC134937
0.8936 High Similarity NPC312393
0.8921 High Similarity NPC192658
0.8913 High Similarity NPC162613
0.8913 High Similarity NPC87934
0.8897 High Similarity NPC79699
0.8881 High Similarity NPC477097
0.8881 High Similarity NPC477099
0.8881 High Similarity NPC477101
0.8865 High Similarity NPC25043
0.8865 High Similarity NPC134131
0.8849 High Similarity NPC473497
0.8841 High Similarity NPC9905
0.8832 High Similarity NPC194769
0.8832 High Similarity NPC285221
0.8824 High Similarity NPC472250
0.8794 High Similarity NPC34943
0.8759 High Similarity NPC290833
0.8759 High Similarity NPC475262
0.8759 High Similarity NPC472247
0.8759 High Similarity NPC265459
0.8741 High Similarity NPC327031
0.8723 High Similarity NPC82467
0.8714 High Similarity NPC266374
0.8705 High Similarity NPC276652
0.8705 High Similarity NPC325805
0.8705 High Similarity NPC272523
0.8671 High Similarity NPC240115
0.8671 High Similarity NPC170668
0.8671 High Similarity NPC477095
0.8671 High Similarity NPC478263
0.8671 High Similarity NPC20255
0.8633 High Similarity NPC86772
0.8601 High Similarity NPC311825
0.8601 High Similarity NPC478264
0.8601 High Similarity NPC92867
0.8601 High Similarity NPC472556
0.8601 High Similarity NPC125882
0.8592 High Similarity NPC153214
0.8592 High Similarity NPC131966
0.8592 High Similarity NPC191387
0.8592 High Similarity NPC95449
0.8582 High Similarity NPC187566
0.8582 High Similarity NPC473654
0.8562 High Similarity NPC96308
0.8552 High Similarity NPC76103
0.8542 High Similarity NPC473602
0.8529 High Similarity NPC272946
0.8514 High Similarity NPC469456
0.8511 High Similarity NPC472547
0.8493 Intermediate Similarity NPC476173
0.8489 Intermediate Similarity NPC232888
0.8489 Intermediate Similarity NPC477367
0.8489 Intermediate Similarity NPC270364
0.8483 Intermediate Similarity NPC473760
0.8472 Intermediate Similarity NPC184817
0.8472 Intermediate Similarity NPC470157
0.8472 Intermediate Similarity NPC470159
0.8472 Intermediate Similarity NPC96903
0.8472 Intermediate Similarity NPC469349
0.8472 Intermediate Similarity NPC174982
0.8472 Intermediate Similarity NPC171525
0.8472 Intermediate Similarity NPC177940
0.8472 Intermediate Similarity NPC70403
0.8472 Intermediate Similarity NPC476973
0.8472 Intermediate Similarity NPC471104
0.8472 Intermediate Similarity NPC29704
0.8472 Intermediate Similarity NPC473088
0.8472 Intermediate Similarity NPC472571
0.8472 Intermediate Similarity NPC472568
0.8472 Intermediate Similarity NPC158663
0.8472 Intermediate Similarity NPC472575
0.8472 Intermediate Similarity NPC200471
0.8472 Intermediate Similarity NPC472572
0.8467 Intermediate Similarity NPC72915
0.8467 Intermediate Similarity NPC319404
0.8462 Intermediate Similarity NPC477094
0.8462 Intermediate Similarity NPC477096
0.8456 Intermediate Similarity NPC70344
0.8451 Intermediate Similarity NPC41481
0.8451 Intermediate Similarity NPC97947
0.8451 Intermediate Similarity NPC291599
0.8451 Intermediate Similarity NPC87448
0.8451 Intermediate Similarity NPC472576
0.8451 Intermediate Similarity NPC118080
0.8451 Intermediate Similarity NPC16912
0.8451 Intermediate Similarity NPC27377
0.8446 Intermediate Similarity NPC471135
0.8444 Intermediate Similarity NPC472706
0.8429 Intermediate Similarity NPC472372
0.8429 Intermediate Similarity NPC472374
0.8417 Intermediate Similarity NPC477368
0.8414 Intermediate Similarity NPC209592
0.8414 Intermediate Similarity NPC48599
0.8403 Intermediate Similarity NPC475759
0.8403 Intermediate Similarity NPC11685
0.8403 Intermediate Similarity NPC25768
0.8403 Intermediate Similarity NPC95810
0.8403 Intermediate Similarity NPC57628
0.8403 Intermediate Similarity NPC188865
0.8403 Intermediate Similarity NPC476974
0.8403 Intermediate Similarity NPC472569
0.8403 Intermediate Similarity NPC472573
0.8403 Intermediate Similarity NPC475122
0.8403 Intermediate Similarity NPC163719
0.8403 Intermediate Similarity NPC470152
0.8403 Intermediate Similarity NPC70716
0.8403 Intermediate Similarity NPC95265
0.8403 Intermediate Similarity NPC241951
0.8403 Intermediate Similarity NPC125106
0.8403 Intermediate Similarity NPC472570
0.84 Intermediate Similarity NPC322048
0.84 Intermediate Similarity NPC318447
0.8392 Intermediate Similarity NPC475135
0.8392 Intermediate Similarity NPC34012
0.8382 Intermediate Similarity NPC472707
0.838 Intermediate Similarity NPC171207
0.838 Intermediate Similarity NPC251294
0.838 Intermediate Similarity NPC275592
0.838 Intermediate Similarity NPC100913
0.838 Intermediate Similarity NPC90614
0.838 Intermediate Similarity NPC97667
0.8369 Intermediate Similarity NPC39549
0.8367 Intermediate Similarity NPC125033
0.8345 Intermediate Similarity NPC477364
0.8344 Intermediate Similarity NPC476784
0.8333 Intermediate Similarity NPC475638
0.8333 Intermediate Similarity NPC475548
0.8333 Intermediate Similarity NPC323001
0.8333 Intermediate Similarity NPC163087
0.8333 Intermediate Similarity NPC326235
0.8333 Intermediate Similarity NPC290683
0.8322 Intermediate Similarity NPC472657
0.8322 Intermediate Similarity NPC472658
0.8322 Intermediate Similarity NPC224491
0.8311 Intermediate Similarity NPC470153
0.831 Intermediate Similarity NPC475195
0.8301 Intermediate Similarity NPC55744
0.8299 Intermediate Similarity NPC476975
0.8299 Intermediate Similarity NPC270590
0.8299 Intermediate Similarity NPC471101
0.8299 Intermediate Similarity NPC266265
0.8299 Intermediate Similarity NPC92293
0.8299 Intermediate Similarity NPC301556
0.8298 Intermediate Similarity NPC472551
0.8298 Intermediate Similarity NPC472545
0.8298 Intermediate Similarity NPC217673
0.8298 Intermediate Similarity NPC477358
0.8298 Intermediate Similarity NPC52523
0.8289 Intermediate Similarity NPC323356
0.8289 Intermediate Similarity NPC326328
0.8289 Intermediate Similarity NPC471138
0.8289 Intermediate Similarity NPC309991
0.8288 Intermediate Similarity NPC474935
0.8286 Intermediate Similarity NPC48929
0.8286 Intermediate Similarity NPC38420
0.8286 Intermediate Similarity NPC136608
0.8286 Intermediate Similarity NPC477359
0.8276 Intermediate Similarity NPC38696
0.8264 Intermediate Similarity NPC472546
0.8258 Intermediate Similarity NPC475567
0.8258 Intermediate Similarity NPC473468
0.8258 Intermediate Similarity NPC473557
0.8255 Intermediate Similarity NPC469648
0.8255 Intermediate Similarity NPC22571
0.8255 Intermediate Similarity NPC138641
0.8255 Intermediate Similarity NPC145649
0.8255 Intermediate Similarity NPC283875
0.8255 Intermediate Similarity NPC233581
0.8255 Intermediate Similarity NPC469647
0.8252 Intermediate Similarity NPC473440

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473301 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8309 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7973 Intermediate Similarity NPD7236 Approved
0.7829 Intermediate Similarity NPD7239 Suspended
0.7826 Intermediate Similarity NPD7799 Discontinued
0.7746 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7718 Intermediate Similarity NPD4628 Phase 3
0.7647 Intermediate Similarity NPD7741 Discontinued
0.7636 Intermediate Similarity NPD7685 Pre-registration
0.7612 Intermediate Similarity NPD2629 Approved
0.7586 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7538 Intermediate Similarity NPD6685 Approved
0.7375 Intermediate Similarity NPD7058 Phase 2
0.7375 Intermediate Similarity NPD7057 Phase 3
0.7313 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD5765 Approved
0.7308 Intermediate Similarity NPD5738 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD6004 Phase 3
0.7285 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD6002 Phase 3
0.7285 Intermediate Similarity NPD6005 Phase 3
0.726 Intermediate Similarity NPD7008 Discontinued
0.7259 Intermediate Similarity NPD6912 Phase 3
0.7248 Intermediate Similarity NPD6653 Approved
0.7244 Intermediate Similarity NPD6273 Approved
0.7234 Intermediate Similarity NPD7457 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD7137 Phase 2
0.7211 Intermediate Similarity NPD3764 Approved
0.7174 Intermediate Similarity NPD4198 Discontinued
0.7172 Intermediate Similarity NPD5740 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD6085 Phase 2
0.7164 Intermediate Similarity NPD2182 Approved
0.7164 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD8434 Phase 2
0.7101 Intermediate Similarity NPD5951 Approved
0.7091 Intermediate Similarity NPD8127 Discontinued
0.7077 Intermediate Similarity NPD1238 Approved
0.7067 Intermediate Similarity NPD6355 Discontinued
0.7063 Intermediate Similarity NPD6287 Discontinued
0.7059 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD7961 Discontinued
0.7045 Intermediate Similarity NPD6647 Phase 2
0.7042 Intermediate Similarity NPD5125 Phase 3
0.7042 Intermediate Similarity NPD5126 Approved
0.7037 Intermediate Similarity NPD5760 Phase 2
0.7037 Intermediate Similarity NPD5761 Phase 2
0.7018 Intermediate Similarity NPD8368 Discontinued
0.6994 Remote Similarity NPD8407 Phase 2
0.6992 Remote Similarity NPD1237 Approved
0.6987 Remote Similarity NPD6190 Approved
0.6962 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6962 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6957 Remote Similarity NPD6858 Approved
0.6957 Remote Similarity NPD7094 Approved
0.6948 Remote Similarity NPD5762 Approved
0.6948 Remote Similarity NPD5763 Approved
0.6944 Remote Similarity NPD4806 Approved
0.6944 Remote Similarity NPD4807 Approved
0.694 Remote Similarity NPD5048 Discontinued
0.6939 Remote Similarity NPD5647 Approved
0.6933 Remote Similarity NPD6663 Approved
0.6932 Remote Similarity NPD8360 Approved
0.6932 Remote Similarity NPD8361 Approved
0.6923 Remote Similarity NPD5305 Approved
0.6923 Remote Similarity NPD5306 Approved
0.6917 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6917 Remote Similarity NPD1930 Approved
0.6917 Remote Similarity NPD1929 Approved
0.6914 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6909 Remote Similarity NPD7075 Discontinued
0.6901 Remote Similarity NPD9545 Approved
0.6894 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6892 Remote Similarity NPD5736 Approved
0.6875 Remote Similarity NPD4136 Approved
0.6875 Remote Similarity NPD5403 Approved
0.6875 Remote Similarity NPD4135 Approved
0.6875 Remote Similarity NPD4106 Approved
0.6871 Remote Similarity NPD6362 Approved
0.6866 Remote Similarity NPD164 Approved
0.6866 Remote Similarity NPD5909 Discontinued
0.6861 Remote Similarity NPD2067 Discontinued
0.6857 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6852 Remote Similarity NPD6599 Discontinued
0.6852 Remote Similarity NPD4380 Phase 2
0.6839 Remote Similarity NPD7266 Discontinued
0.6836 Remote Similarity NPD8435 Approved
0.6829 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6821 Remote Similarity NPD7715 Approved
0.6821 Remote Similarity NPD6764 Approved
0.6821 Remote Similarity NPD6765 Approved
0.6821 Remote Similarity NPD7714 Approved
0.6818 Remote Similarity NPD8150 Discontinued
0.6818 Remote Similarity NPD7305 Phase 1
0.6818 Remote Similarity NPD7033 Discontinued
0.6815 Remote Similarity NPD8166 Discontinued
0.6812 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6806 Remote Similarity NPD7163 Clinical (unspecified phase)
0.6806 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6797 Remote Similarity NPD3528 Clinical (unspecified phase)
0.679 Remote Similarity NPD7458 Discontinued
0.6788 Remote Similarity NPD5402 Approved
0.6779 Remote Similarity NPD5204 Approved
0.6768 Remote Similarity NPD6801 Discontinued
0.6757 Remote Similarity NPD3094 Phase 2
0.6752 Remote Similarity NPD7421 Clinical (unspecified phase)
0.675 Remote Similarity NPD5401 Approved
0.6747 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6743 Remote Similarity NPD8312 Approved
0.6743 Remote Similarity NPD8313 Approved
0.6742 Remote Similarity NPD9495 Approved
0.6736 Remote Similarity NPD4105 Approved
0.6736 Remote Similarity NPD4102 Approved
0.6733 Remote Similarity NPD6832 Phase 2
0.6732 Remote Similarity NPD230 Phase 1
0.6731 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6727 Remote Similarity NPD8455 Phase 2
0.6727 Remote Similarity NPD7819 Suspended
0.6709 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6709 Remote Similarity NPD2575 Approved
0.6707 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6703 Remote Similarity NPD8485 Approved
0.6692 Remote Similarity NPD7798 Approved
0.6692 Remote Similarity NPD2066 Phase 3
0.6689 Remote Similarity NPD1876 Approved
0.6687 Remote Similarity NPD6799 Approved
0.6667 Remote Similarity NPD3661 Approved
0.6667 Remote Similarity NPD1608 Approved
0.6667 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6785 Approved
0.6667 Remote Similarity NPD7497 Discontinued
0.6667 Remote Similarity NPD2935 Discontinued
0.6667 Remote Similarity NPD3662 Phase 3
0.6667 Remote Similarity NPD7009 Phase 2
0.6667 Remote Similarity NPD3664 Approved
0.6667 Remote Similarity NPD6784 Approved
0.6667 Remote Similarity NPD3663 Approved
0.6647 Remote Similarity NPD7768 Phase 2
0.6644 Remote Similarity NPD2797 Approved
0.6623 Remote Similarity NPD4617 Approved
0.6623 Remote Similarity NPD4620 Approved
0.6623 Remote Similarity NPD5203 Approved
0.6623 Remote Similarity NPD5201 Approved
0.6604 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6604 Remote Similarity NPD3750 Approved
0.6604 Remote Similarity NPD4110 Phase 3
0.6604 Remote Similarity NPD7488 Clinical (unspecified phase)
0.6604 Remote Similarity NPD7003 Approved
0.6603 Remote Similarity NPD2799 Discontinued
0.6603 Remote Similarity NPD4308 Phase 3
0.6601 Remote Similarity NPD6233 Phase 2
0.6601 Remote Similarity NPD7713 Phase 3
0.6597 Remote Similarity NPD7610 Discontinued
0.6595 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6588 Remote Similarity NPD7199 Phase 2
0.6587 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6585 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6584 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6579 Remote Similarity NPD7095 Approved
0.6577 Remote Similarity NPD5667 Approved
0.6575 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6566 Remote Similarity NPD37 Approved
0.6565 Remote Similarity NPD1202 Approved
0.6561 Remote Similarity NPD1551 Phase 2
0.6558 Remote Similarity NPD5119 Approved
0.6558 Remote Similarity NPD4140 Approved
0.6558 Remote Similarity NPD5121 Approved
0.6558 Remote Similarity NPD5120 Approved
0.6552 Remote Similarity NPD5844 Phase 1
0.6552 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6548 Remote Similarity NPD4965 Approved
0.6548 Remote Similarity NPD4967 Phase 2
0.6548 Remote Similarity NPD4966 Approved
0.6536 Remote Similarity NPD6798 Discontinued
0.6536 Remote Similarity NPD4621 Approved
0.6536 Remote Similarity NPD4619 Approved
0.6536 Remote Similarity NPD3268 Approved
0.6536 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6536 Remote Similarity NPD2313 Discontinued
0.6534 Remote Similarity NPD6559 Discontinued
0.6528 Remote Similarity NPD9493 Approved
0.6528 Remote Similarity NPD694 Clinical (unspecified phase)
0.6525 Remote Similarity NPD969 Suspended
0.6516 Remote Similarity NPD5735 Approved
0.6513 Remote Similarity NPD5202 Clinical (unspecified phase)
0.6506 Remote Similarity NPD7411 Suspended
0.65 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6494 Remote Similarity NPD3818 Discontinued
0.649 Remote Similarity NPD2798 Approved
0.6488 Remote Similarity NPD3817 Phase 2
0.6486 Remote Similarity NPD3092 Approved
0.6485 Remote Similarity NPD3226 Approved
0.6485 Remote Similarity NPD3455 Phase 2
0.6478 Remote Similarity NPD5958 Discontinued
0.6478 Remote Similarity NPD4534 Discontinued
0.6477 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6474 Remote Similarity NPD7997 Clinical (unspecified phase)
0.6471 Remote Similarity NPD1932 Approved
0.6471 Remote Similarity NPD6234 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data